Status:

RECRUITING

Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Leukemia,Myeloid, Chronic

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

French prospective multicenter, open-label study involving newly diagnosed CML patients. Two assessments will be performed during the follow-up of these patients: individual frailty using geriatric to...

Eligibility Criteria

Inclusion

  • Age ≥18 years
  • CML in chronic phase at time of diagnosis. Diagnosis must be made no more than 3 months (90 days) prior to inclusion. Diagnosis of chronic-phase CML (European Leukemia Network \[ELN\] 2020 criteria; Baccarani et al 2013) with confirmation of a Philadelphia chromosome (Ph1). A cryptic Ph1 chromosome must be confirmed by FISH.Criteria must meet the definition of chronic phase CML
  • BCR ::ABL1 transcript quantifiable by quantitative PCR
  • 1st-line treatment with tyrosine kinase inhibitor
  • No tyrosine kinase inhibitor or hydroxyurea treatment received prior to first blood sampling (at diagnosis)
  • Signature of informed consent for CML Observatory and signature of informed consent for BIO-TIMER protocol
  • Read and understand French
  • Enrolled in a social security plan or beneficiary of such a plan

Exclusion

  • CML in accelerated or blast phase
  • Refusal to participate in the study
  • Treatment started prior to inclusion
  • Patients under guardianship, curatorship, deprivation of liberty or safeguard of justice
  • Pregnant or breast-feeding women

Key Trial Info

Start Date :

November 17 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 17 2028

Estimated Enrollment :

321 Patients enrolled

Trial Details

Trial ID

NCT06130787

Start Date

November 17 2023

End Date

November 17 2028

Last Update

September 27 2024

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

CHU Annecy-Genevois

Annecy, France

2

Institut Bergonié

Bordeaux, France

3

CHU Caen

Caen, France

4

CHU de Clermont-Ferrand

Clermont-Ferrand, France, 63000